BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 38 filers reported holding BIONTECH SE in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,567,381 | +2.1% | 88,065 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $9,370,482 | -10.8% | 86,820 | +3.0% | 0.00% | 0.0% |
| Q1 2023 | $10,502,745 | +83801.1% | 84,312 | +1.2% | 0.00% | -50.0% |
| Q4 2022 | $12,518 | -99.9% | 83,332 | +4.9% | 0.00% | 0.0% |
| Q3 2022 | $10,717,000 | -7.0% | 79,462 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $11,523,000 | +2.3% | 77,290 | +17.0% | 0.00% | +100.0% |
| Q1 2022 | $11,263,000 | -33.7% | 66,040 | +0.2% | 0.00% | -50.0% |
| Q4 2021 | $16,984,000 | +5.6% | 65,882 | +11.8% | 0.00% | 0.0% |
| Q3 2021 | $16,085,000 | +25.9% | 58,924 | +3.3% | 0.00% | 0.0% |
| Q2 2021 | $12,775,000 | +109.8% | 57,064 | +2.3% | 0.00% | +100.0% |
| Q1 2021 | $6,088,000 | +55.2% | 55,760 | +15.9% | 0.00% | 0.0% |
| Q4 2020 | $3,923,000 | +41.9% | 48,125 | +20.5% | 0.00% | 0.0% |
| Q3 2020 | $2,765,000 | +529.8% | 39,947 | +506.5% | 0.00% | – |
| Q2 2020 | $439,000 | +24.4% | 6,586 | +8.9% | 0.00% | – |
| Q1 2020 | $353,000 | – | 6,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
| Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
| Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
| Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
| Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
| Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
| Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
| Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
| Robbins Farley | 13,220 | $2,255,000 | 1.70% |
| APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |